Array
(
[1596658271] => Array
(
[wordfence_batchReportFailedAttempts] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] =>
[args] => Array
(
)
)
)
)
[1596659973] => Array
(
[wp_privacy_delete_old_export_files] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1596660400] => Array
(
[wordfence_hourly_cron] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1596660481] => Array
(
[wpm_update_stats] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1596660518] => Array
(
[w3_pgcache_cleanup] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => w3_pgcache_cleanup
[args] => Array
(
)
[interval] => 3600
)
)
)
[1596677526] => Array
(
[wp_update_themes] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
[wp_update_plugins] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1596680953] => Array
(
[wp_version_check] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1596683873] => Array
(
[wp_session_garbage_collection] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1596695085] => Array
(
[recovery_mode_clean_expired_keys] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596697712] => Array
(
[ai1wm_storage_cleanup] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596703771] => Array
(
[wp_scheduled_auto_draft_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596708911] => Array
(
[delete_expired_transients] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596708952] => Array
(
[wpseo-reindex-links] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596710800] => Array
(
[wordfence_daily_cron] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596721474] => Array
(
[wp_scheduled_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596721800] => Array
(
[wordfence_start_scheduled_scan] => Array
(
[ea3d84ad85af7f7ab7cbfe8f778632cc] => Array
(
[schedule] =>
[args] => Array
(
[0] => 1596721800
)
)
)
)
[1596730024] => Array
(
[akismet_scheduled_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596733011] => Array
(
[yoast_tracking] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1596981000] => Array
(
[wordfence_start_scheduled_scan] => Array
(
[66ba68d2add5c4cdada519ad9b8d74a5] => Array
(
[schedule] =>
[args] => Array
(
[0] => 1596981000
)
)
)
)
[1597068000] => Array
(
[wordfence_email_activity_report] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] =>
[args] => Array
(
)
)
)
)
[1597213490] => Array
(
[wp_site_health_scheduled_check] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => weekly
[args] => Array
(
)
[interval] => 604800
)
)
)
[1601157627] => Array
(
[publish_future_post] => Array
(
[aa3f9c41dd8e97586795881a0c603b8d] => Array
(
[schedule] =>
[args] => Array
(
[0] => 472787
)
)
)
)
)
Etiquetas: Aparición del medicamento genérico y protección del medicamento innovador, Apariencia de los genéricos, Bioequivalencia, Bioequivalencia de los medicamentos genéricos, Calidad de los medicamentos genéricos, Concepto de medicamento genérico, División de Farmacología, Equivalencia, Estudios farmacocinéticos de bioequivalencia, Evaluación Clínica, Evidencias, Excipientes, genéricos, Intercambiabilidad, Marzo 2010, Medicamento genérico e intercambiabilidad, Medicamento genérico y políticas de sustitución, Médicamentos genéricos, Mitos, Regulación de los medicamentos genéricos, salud, Sanidad, Servicio de Farmacocinética, Subdirección general de Medicamentos de Uso Humano.
Etiquetas: 13 julio 2007, 2007, Agencia Española de Medicamentos y Productos Sanitarios. 13 de Julio de 2007, Alterar la función renal, Antes de verano, Comunicado de seguridad, Conservación de los medicamentos en caso de ola de calor, Cristina Avedaño Solá, Durante la ola de calor, Factores de riesgo, Golpe de calor, Hidratación, Información sobre buen uso de los medicamentos en caso de ola de calor, Información sobre pacientes con situaciones clínicas especiales en caso de ola de calor, Madrid, Medicamantos que se pueden agravar indirectamente los efectos del calor, medicamentos, Medicamentos que pueden inducir una hipertermia, Ministerio de Sanidad y Consumo, Patologías cronicas, Perdida calórica del organismo, Perfil cinetico, Personas con patología cardiovascular, Personas con patología Endocrina, Personas con patología uronefrológica, Plan de prevención de altas temperaturas, recomendaciones, Riesgos inducidos por los medicamentos enla adaptación del organismo al calor, salud, Sanidad, Subdirección general de Medicamentos de Uso Humano, Terapias farmacológicamente prolongadas en el tiempo.
.gif)